1. Chemokines in colon cancer progression
   Sheng-Nan Jia et al, 2022, Seminars in Cancer Biology CrossRef
2. “DEPHENCE” system—a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer—a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies
   Jacek R. Wilczyński et al, 2023, Frontiers in Oncology CrossRef
3. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy
   David Schweer et al, 2022, Cancers CrossRef
4. Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
   Takashi Oshima et al, 2022, Scientific Reports CrossRef
5. Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer
   Ji Wang et al, 2023, Biology CrossRef
6. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy
   Subhankar Bose et al, 2022, Seminars in Cancer Biology CrossRef
7. Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell lines
   Manny D. Bacolod et al, 2023, Epigenetic Regulation of Cancer in Response to Chemotherapy CrossRef
8. HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20
   Lumin Wang et al, 2024, Cell Death & Disease CrossRef
9. Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
   Louis Boafo Kwantwi et al, 2021, Bioengineered CrossRef
10. Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
    Jacek R Wilczyński et al, 2022, International Journal of Molecular Sciences CrossRef